STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $502,669 | -1.1% | 127,581 | +166.9% | 0.01% | 0.0% |
| Q2 2023 | $508,071 | -51.4% | 47,796 | -62.0% | 0.01% | -55.2% |
| Q1 2023 | $1,046,456 | +29.5% | 125,625 | +43.5% | 0.03% | +26.1% |
| Q4 2022 | $807,893 | +26.2% | 87,529 | +75.6% | 0.02% | 0.0% |
| Q3 2022 | $640,000 | -42.1% | 49,856 | -40.4% | 0.02% | -54.0% |
| Q2 2022 | $1,105,000 | +225.0% | 83,657 | +418.1% | 0.05% | +212.5% |
| Q1 2022 | $340,000 | -46.3% | 16,146 | -38.8% | 0.02% | -59.0% |
| Q4 2021 | $633,000 | +110.3% | 26,399 | +195.0% | 0.04% | +56.0% |
| Q2 2021 | $301,000 | -2.0% | 8,949 | +13.3% | 0.02% | -10.7% |
| Q1 2021 | $307,000 | – | 7,896 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |